Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma
新型BTK抑制剂TG-1701的抗肿瘤活性与B细胞非霍奇金淋巴瘤患者中Ikaros信号通路的破坏有关
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-1067
Ribeiro, Marcelo Lima; Reyes-Garau, Diana; Vinyoles, Meritxell; Profitós Pelejà, Núria; Santos, Juliana Carvalho; Armengol, Marc; Fernández-Serrano, Miranda; Sedó Mor, Alícia; Bech-Serra, Joan J; Blecua, Pedro; Musulen, Eva; De La Torre, Carolina; Miskin, Hari; Esteller, Manel; Bosch, Francesc; Menéndez, Pablo; Normant, Emmanuel; Roué, Gaël
B细胞
肿瘤
Ikaros
肿瘤免疫
信号转导
淋巴瘤
BTK
细胞生物学
免疫/内分泌